<DOC>
	<DOCNO>NCT01280877</DOCNO>
	<brief_summary>Aim validate non-invasive brain stimulation increase cortical excitability visual system . The investigator assess transcranial alternate current stimulation ( tACS ) improve visual field size patient optic nerve damage . Hypothesis : tACS would improve visual function within defective visual field ( primary outcome measure ) .</brief_summary>
	<brief_title>Paraorbital-Occipital Alternating Current Stimulation Therapy Optic Neuropathy ( MCT_optnerve )</brief_title>
	<detailed_description>In addition , correlation brain-derived neurotrophic factor ( BDNF ) plasticity marker correlate improvement visual field stimulation .</detailed_description>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Optic Nerve Diseases</mesh_term>
	<mesh_term>Nervous System Diseases</mesh_term>
	<mesh_term>Optic Nerve Injuries</mesh_term>
	<criteria>patient optic nerve lesion stable visual field defect residual vision lesion age least 6 month age least 18 year completely blindness , residual vision still existent electric electronic implant , e.g . heart pacemaker metal artefact head truncus epilepsy autoimmune disease acute stage mental disease , e.g . schizophrenia etc . unstable diabetes , diabetes cause diabetic retinopathy addiction high blood pressure ( max . 160/100 mmHg ) instable high level intraocular pressure ( i.e . &gt; 27 mmHg ) retinitis pigmentosa pathological nystagmus presence unoperated tumor anywhere body pregnant breastfeed woman photo sensibility Fundus hypertonicus acute conjunctivitis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>optic neuropathy</keyword>
	<keyword>visual field</keyword>
	<keyword>electric stimulation</keyword>
	<keyword>alternate current</keyword>
	<keyword>perimetry</keyword>
</DOC>